Patent · US Active

Use of derivatives of indoles for the treatment of cancer

US9212138B2 · kind B2 · utility

0Cited by

3References

12Claims

0Family size

Assignees

COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Catherine Guillou · Gif-sur-Yvette, FR
Frank Kozielski · Hamburg, DE
Christophe Labriere · Brest, FR
Francoise Gueritte · Gif-sur-Yvette, FR
Sergey Tcherniuk · Fontaine, FR
Dimitrios Skoufias · Fontaine, FR
Claude Thal · Sceaux, FR
Henri-Philippe Husson · Chevreuse, FR

Key dates

Filing date	Feb 12, 2014
Grant date	Dec 15, 2015
Priority date	—
Expiry date	Feb 24, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention relates to the use of derivatives of indoles having a general formula (I) as follow:for the manufacture of a pharmaceutical composition intended for the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.